Results 311 to 320 of about 383,810 (341)
An integrated approach that combines a DNA nanoflower VEGF degrader with photodynamic therapy is developed for the treatment of wet age‐related macular degeneration, which reduces the risk of VEGF reactivation‐induced CNV recurrence and minimizes the systemic side effects associated with photodynamic therapy.
Mengxuan Li +11 more
wiley +1 more source
Lymphatic Endothelial Cells and Organ-Associated Lymphangiogenesis in Tumor Microenvironment. [PDF]
Ji RC.
europepmc +1 more source
This study identifies ESM1 as an endogenous anticoagulant that modulates venous thrombosis. It shows that ESM1 deficiency triggers vascular occlusion in zebrafish and mice, whereas its restoration or overexpression prolongs clot‐formation time. Mechanistic analyses reveal that ESM1 activates HCII through its dermatan‐sulfate chain, uncovering a ...
Changsheng Chen +10 more
wiley +1 more source
Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration. [PDF]
Schmidt I +6 more
europepmc +1 more source
Submacular Hemorrhage Management: Evolving Strategies from Pharmacologic Displacement to Surgical Intervention. [PDF]
Sarna M, Waszczykowska A.
europepmc +1 more source
VEGF-based Therapy for Congenital Diaphragmatic Hernia: A Breakthrough or a Hidden Risk? [PDF]
Zeng X.
europepmc +1 more source
Thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in human bladder cancer. [PDF]
Hwang TI +6 more
europepmc +1 more source
Morphovascular aspects and VEGF expression in mare placenta
Luciana Araújo Lins
openalex +1 more source
The interplay between TGF-β and VEGF signalling in endothelial cell function
Zhen Liu
openalex +1 more source

